Zim Laboratories vs Peers
- Market cap
- ₹756 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹101.70 – ₹190.69
Zim Laboratories ranks 1st by market capitalisation among 1 Drug Manufacturers - Specialty & Generic companies tracked by ATS. Its largest peers are ZIM Laboratories. Its P/E of 22.5 compares with a peer median of 22.5.
Zim Laboratories vs Drug Manufacturers - Specialty & Generic peers
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| ZIM Laboratories | 141.25 | -3.66% | 756 | 22.5 | 2.85 | 14.5% | +18.5% |
| Zim Laboratories | 141.25 | -3.66% | 756 | 22.5 | 2.85 | 14.5% | +24.5% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 9 October 2026. How this data is compiled.
Zim Laboratories peer comparison — frequently asked questions
Who are Zim Laboratories' competitors?
Zim Laboratories' listed peers in Drug Manufacturers - Specialty & Generic include ZIM Laboratories, ranked here by market capitalisation.
How does Zim Laboratories' P/E compare with its peers?
Zim Laboratories trades at a P/E of 22.5, against a median of 22.5 across the 1 Drug Manufacturers - Specialty & Generic peers shown.
Which is the largest company among Zim Laboratories' peers?
By market capitalisation, the largest company in the group is ZIM Laboratories at ₹756 crore, against ₹756 crore for Zim Laboratories.
Same Data For Peers
Trade Zim Laboratories With ATS
Track ZIMLAB live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.